Dissociable hindbrain GLP1R circuits for satiety and aversion
Open accessAbstract
The most successful obesity therapeutics, glucagon-like peptide-1 receptor (GLP1R) agonists, cause aversive responses such as nausea and vomiting1,2, effects that may contribute to their efficacy. Here, we investigated the brain circuits that link satiety to aversion, and unexpectedly discovered that the neural circuits mediating these effects are functionally separable. Systematic investigation across drug-accessible GLP1R populations revealed that only hindbrain neurons are required for the efficacy of GLP1-based obesity drugs. In vivo two-photon imaging of hindbrain GLP1R neurons demonstrated that most neurons are tuned to either nutritive or aversive stimuli, but not both. Furthermore, simultaneous imaging of hindbrain subregions indicated that area postrema (AP) GLP1R neurons are broadly responsive, whereas nucleus of the solitary tract (NTS) GLP1R neurons are biased towards nutritive stimuli. Strikingly, separate manipulation of these populations demonstrated that activation of NTSGLP1R neurons triggers satiety in the absence of aversion, whereas activation of APGLP1R neurons triggers strong aversion with food intake reduction. Anatomical and behavioural analyses revealed that NTSGLP1R and APGLP1R neurons send projections to different downstream brain regions to drive satiety and aversion, respectively. Importantly, GLP1R agonists reduce food intake even when the aversion pathway is inhibited. Overall, these findings highlight NTSGLP1R neurons as a population that could be selectively targeted to promote weight loss while avoiding the adverse side effects that limit treatment adherence. The neural circuits in the hindbrain that link satiety and aversion are shown to be separate, raising the possibility of developing obesity drugs without the common side effects of nausea and vomiting.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 33 cited sources checked · 0 supported · 0 flagged
- Findingown data
DVC GLP1R deletion attenuated both the anorexic and aversive effects of semaglutide.
“DVCGLP1R deletion attenuated both the anorexic and aversive effects of semaglutide”
Quote in the paperSubstantial claim - Findingown data
Acute or chronic activation of DVC GLP1R neurons decreased total energy expenditure.
“as acute or chronic activation of DVCGLP1R neurons decreased total energy expenditure”
Quote in the paperNot a substantial claim - Findingown data
Activation of DVC GLP1R neurons conditioned flavor avoidance in the CFA assay.
“activation of DVCGLP1R neurons conditioned a flavour avoidance”
Quote in the paperSubstantial claim - Findingown data
Chemogenetic inhibition of AP GLP1R neurons, but not NTS GLP1R neurons, blunted conditioned flavor avoidance to a semaglutide-paired flavor.
“Chemogenetic inhibition (hM4Di) of APGLP1R neurons, but not NTSGLP1R neurons, blunted the CFA to a semaglutide-paired flavour”
Quote in the paperSubstantial claim - Findingown data
Inhibiting AP or NTS GLP1R neurons did not block food intake suppression by GLP1-based obesity drugs.
“inhibiting neural activity in either population did not block the food intake suppression by GLP1-based obesity drugs”
Quote in the paperSubstantial claim
- Findingown data
DVC GLP1R neurons send ascending projections to the lPBN and PVH.
“These data revealed ascending projections to two regions – the lateral parabrachial nucleus (lPBN) and paraventricular hypothalamus (PVH)”
Quote in the paperSubstantial claim - Findingown data
Chronic activation of DVC GLP1R neurons prevented weight gain and fat mass accumulation in mice maintained on a high-fat diet.
“but also prevented weight gain and fat mass accumulation in mice maintained on a high-fat diet”
Quote in the paperSubstantial claim - Findingown data
Ablation of DVC GLP1R neurons completely blocked food intake suppression by exendin-4 and semaglutide.
“Ablation of DVCGLP1R neurons, but not the populations in the ARC or NG, completely blocked food intake suppression by both exendin-4”
Quote in the paperSubstantial claim - Findingown data
Optogenetic activation of AP GLP1R→lPBN or NTS GLP1R→PVH neurons significantly inhibited food intake in ChR2-expressing mice but not in EYFP-expressing controls.
“Activation of either APGLP1R→lPBN or NTSGLP1R→PVH neurons significantly inhibited food intake in ChR2-expressing (Fig. 5g) but not EYFP-expressing”
Quote in the paperSubstantial claim - Findingown data
When nutrients were compared with LiCl, only NTS GLP1R neurons showed a bias toward Ensure over LiCl.
“When comparing calcium responses to nutrients with those to LiCl, there was also a bias in responsivity, but only in the NTS which was again more tuned to Ensure compared to the aversive stimulus LiCl”
Quote in the paperSubstantial claim- Rests on an assumption: Ensure administered intraduodenally is a nutritive stimulus.
- Rests on an assumption: Lithium chloride administered intravenously is an aversive or nauseogenic stimulus.
- Findingown data
Deleting GLP1R from the AP, but not the NTS, blunted aversion responses to semaglutide.
“deleting GLP1R from the AP, but not the NTS, blunted aversion responses to semaglutide”
Quote in the paperSubstantial claim - Findingown data
AP GLP1R and NTS GLP1R neurons send largely separate projections to the lPBN and PVH, respectively.
“Analysis of DVC sections indicated that APGLP1R and NTSGLP1R neurons send largely separate projections to the lPBN and PVH, respectively”
Quote in the paperSubstantial claim - Findingown data
Most activated DVC GLP1R neurons responded to either Ensure or cinacalcet, with only 6% responding to both.
“Overall, most activated DVCGLP1R neurons were responsive to either Ensure or cinacalcet, with few neurons (6%) responsive to both stimuli”
Quote in the paperSubstantial claim- Rests on an assumption: Ensure administered intraduodenally is a nutritive stimulus.
- Rests on an assumption: Lithium chloride administered intravenously is an aversive or nauseogenic stimulus.
- Findingown data
AP and NTS GLP1R neurons are largely distinct from other DVC cell types.
“This analysis also suggests that APGLP1R and NTSGLP1R neurons are largely distinct from other DVC cell types”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [13] Zhang, C. et al. Area postrema cell types that mediate nausea-associated behaviors. Neuron 109, 461–472 (2021). source
Not checked in the free run.
- cites [16] Ludwig, M. Q. et al. A genetic map of the mouse dorsal vagal complex and its role in obesity. Nat. Metab. 3, 530–545 (2021). source
Not checked in the free run.
- cites [17] Adriaenssens, A. et al. Hypothalamic and brainstem glucose-dependent insulinotropic polypeptide receptor neurons employ distinct mechanisms to affect feeding. 8, https://doi.org/10.1172/jci.insight.164921 (2023). source
Not checked in the free run.
- Findingown data
DVC GLP1R neuron ablation blunted semaglutide-induced weight loss in obese mice.
“DVCGLP1R neuron ablation, but not ablation of ARCGLP1R or NGGLP1R neurons, blunted weight loss by semaglutide in obese mice”
Quote in the paperSubstantial claim - Findingown data
Chronic activation of DVC GLP1R neurons reduced body weight in lean, chow-fed mice.
“Chronic activation of DVCGLP1R neurons not only reduced body weight in lean, chow fed mice”
Quote in the paperSubstantial claim - Findingown data
Acute chemogenetic activation of DVC GLP1R neurons potently suppressed food intake in food-deprived mice.
“Acute chemogenetic (hM3Dq) activation of DVCGLP1R neurons potently suppressed food intake in food deprived mice”
Quote in the paperSubstantial claim - Findingown data
Similar proportions of AP and NTS GLP1R neurons were activated by semaglutide.
“similar proportions of neurons were activated in the AP and NTS”
Quote in the paperNot a substantial claim - Findingown data
Chronic activation of NTS GLP1R neurons is sufficient to reduce body weight.
“Importantly, chronic activation of NTSGLP1R neurons is sufficient to reduce body weight”
Quote in the paperSubstantial claim - Findingown data
The latency to semaglutide-induced activation was similar between AP and NTS GLP1R neurons.
“the latency to semaglutide-induced activation was similar when comparing APGLP1R to NTSGLP1R neurons”
Quote in the paperNot a substantial claim - Findingown data
DVC GLP1R neuron ablation blunted the long-term prevention of weight gain by semaglutide in mice maintained on a high-fat diet.
“ablation of DVCGLP1R neurons also blunted the long-term prevention of weight gain by semaglutide in mice maintained on a high-fat diet”
Quote in the paperSubstantial claim - Findingown data
Activation of AP or NTS GLP1R neurons inhibited food intake to the same magnitude.
“Activation of either APGLP1R (Fig. 3f) or NTSGLP1R (Fig. 3g) neurons inhibited food intake to the same magnitude”
Quote in the paperSubstantial claim - Findingown data
Chronic NaChBac-mediated DVCGLP1R neuron activation reduced cumulative food intake in high-fat diet-fed mice compared with controls (p<0.001).
“(b) Cumulative food intake in high-fat diet-fed control mice or mice with chronic NaChBac-mediated DVCGLP1R neuron activation (n=7–8 mice/group, two-way repeated measures ANOVA, control vs. NaChBac: p<0.001).”
Quote in the paperSubstantial claim - Findingown data
In high-fat diet-fed mice receiving semaglutide, DVCGLP1R neuron ablation altered percent body weight change compared with controls (p<0.001).
“(f) Percent body weight change during the onset of diet-induced obesity in high-fat diet-fed control (EGFP) or DVCGLP1R neuron-ablated mice receiving semaglutide (n=11–15 mice/group, two-way repeated measures ANOVA, control vs. DVC-Casp3 p<0.001).”
Quote in the paperSubstantial claim - Findingown data
Chronic NaChBac-mediated DVCGLP1R neuron activation did not alter average meal size in high-fat diet-fed mice (p=ns).
“(d) Average meal size in high-fat diet-fed control mice or mice with chronic NaChBac-mediated DVCGLP1R neuron activation (n=7–8 mice/group, two-sided unpaired t-test, control vs. NaChBac: p=ns).”
Quote in the paperSubstantial claim - Findingcitation
A minority of NTS GLP1R neurons express CCK.
“Given that a minority of NTSGLP1R neurons express CCK (Extended Data Fig. 8q)16”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [16] Ludwig, M. Q. et al. A genetic map of the mouse dorsal vagal complex and its role in obesity. Nat. Metab. 3, 530–545 (2021). source
Not checked in the free run.
- Findingown data
Body weight at 8 weeks after surgery did not differ among control, DVC, ARC, and NG GLP1R neuron ablation groups.
“(e) Body weight at 8 weeks post-surgery in control, DVC, ARC, and NG GLP1R neuron ablation groups (n=7–8 mice/group, one-way ANOVA, p=ns).”
Quote in the paperNot a substantial claim - Findingown data
Chronic NaChBac-mediated DVCGLP1R neuron activation altered average inter-meal interval in high-fat diet-fed mice compared with controls (p<0.01).
“(c) Average inter-meal interval of high-fat diet-fed control mice or mice with chronic NaChBac-mediated DVCGLP1R neuron activation (n=7–8 mice/group, two-sided unpaired t-test, control vs. NaChBac: p<0.01).”
Quote in the paperSubstantial claim - Findingown data
Activation of AP or NTS GLP1R neurons leads to the same magnitude of food intake suppression as activating both populations.
“activation of APGLP1R or NTSGLP1R neurons leads to the same magnitude of food intake suppression as activating both”
Quote in the paperSubstantial claim - Findingown data
Caspase3- or DTA-mediated ablation reduced the relative number of GLP1R+ neurons in the DVC, ARC, and NG compared with controls (all p<0.01).
“(c) Quantification of Caspase3- or DTA-mediated neural ablation: relative number (to controls) of GLP1R+ neurons in DVC (left), ARC (middle), and NG (right) of mice with viral injection into DVC, ARC, or NG, respectively (n=3–5 mice/group, two-sided unpaired t-tests, all ps<0.01).”
Quote in the paperSubstantial claim - Findingown data
Dark period energy expenditure normalized to body mass differed between chow-fed control mice and mice with chemogenetic DVCGLP1R neuron activation (p<0.001).
“(h) Dark period energy expenditure normalized to body mass by ANCOVA in chow-fed control mice or mice with chemogenetic DVCGLP1R neuron activation (n=8 mice/group, ANCOVA, p<0.001).”
Quote in the paperNot a substantial claim - Findingown data
A flavour paired with LiCl altered conditioned hedonic and aversive taste reactivity composite scores and individual behaviours.
“Composite scores (m, n=5 mice/group, two-sided paired t-tests, ps<0.05) and individual behaviours (n=6 mice/group, two-way ANOVA, RMM: p<0.05, G: p<0.001, CR: p<0.05) for conditioned hedonic and aversive taste reactivity responses to a flavour paired with LiCl (6 mmol/kg, IP).”
Quote in the paperSubstantial claim - Findingown data
The median time to semaglutide-induced activation did not differ between AP and NTS GLP1R neurons.
“Median time to semaglutide-induced activation in APGLP1R and NTSGLP1R neurons depicted in h (n=5 mice, two-sided unpaired t-test, p=ns).”
Quote in the paperNot a substantial claim - Findingown data
A flavour paired with cinacalcet altered real-time hedonic and aversive taste reactivity composite scores and individual behaviours.
“Composite scores (g, n=6 mice/group, two-sided paired t-tests, ps<0.05) and individual behaviours (h, 6 mice/group, two-way ANOVA, RMM: p<0.05, G: p<0.001) for real-time hedonic and aversive taste reactivity responses to a flavour paired with cinacalcet (15 μmol/kg, IP).”
Quote in the paperNot a substantial claim - Findingown data
A flavour paired with cinacalcet altered conditioned hedonic and aversive taste reactivity composite scores and individual behaviours.
“Composite scores (i, n=6 mice/group, two-sided paired t-tests, aversive: p<0.05) and individual behaviours (j, 6 mice/group, two-way ANOVA, G: p<0.001) for conditioned hedonic and aversive taste reactivity responses to a flavour paired with cinacalcet (15 μmol/kg, IP).”
Quote in the paperNot a substantial claim - Findingown data
Semaglutide activated similar proportions of AP and NTS GLP1R neurons.
“Proportion of APGLP1R and NTSGLP1R neurons activated by semaglutide (n=5 mice, two-sided paired t-test, p=ns).”
Quote in the paperNot a substantial claim - Findingown data
DVC injection of AAV2.2-Cre reduced the relative number of Glp1r+ neurons in Glp1rfl/fl mice compared to WT mice.
“Quantification of efficacy of GLP1R deletion: relative number of Glp1r+ neurons in the DVC in WT and Glp1rfl/fl mice after DVC injection of AAV2.2-Cre (n=3 mice/group, two-sided unpaired t-test, p<0.001).”
Quote in the paperSubstantial claim - Findingown data
Chemogenetic stimulation of DVC GLP1R neurons increased colocalization of Fos and Calca in the lPBN.
“Representative images (left) and quantification (right) of colocalization of Fos and Calca in the lPBN after control (vehicle) or chemogenetic (CNO) stimulation (n=3 mice/group, two-sided unpaired t-test, p<0.05).”
Quote in the paperNot a substantial claim - Findingown data
Chemogenetic stimulation of DVC GLP1R neurons during conditioning changed hedonic taste reactivity behaviours in experimental mice but not in control mice.
“Individual hedonic taste reactivity behaviours at baseline and after conditioning in control (p, n=6 mice/group, two-way ANOVA, all ps=ns) and experimental (q, n=7 mice/group, two-way ANOVA, RMM: p<0.001, LTP: p<0.05) mice.”
Quote in the paperSubstantial claim - Findingown data
Chemogenetic activation of DVC, AP, and NTS GLP1R neurons significantly altered 12-h food intake.
“12-h food intake in mice following activation of DVCGLP1R, APGLP1R, and NTSGLP1R neurons (n=7–11 mice/group, two-way ANOVA, all ps<0.001).”
Quote in the paperSubstantial claim - Findingown data
Chemogenetic stimulation of DVC GLP1R neurons during conditioning changed aversive taste reactivity behaviours in experimental mice but not in control mice.
“Individual aversive taste reactivity behaviours at baseline and after conditioning in control (r, n=6 mice/group, two-way ANOVA, all ps=ns) and experimental (s, n=7 mice/group, two-way ANOVA, G: p<0.01, CR: p<0.001) mice.”
Quote in the paperSubstantial claim - Findingown data
Chemogenetic stimulation of DVC GLP1R neurons increased colocalization of Fos and Mc4r in the PVH.
“Representative images (left) and quantification of colocalization (right) of Fos and Mc4r in the PVH after control (vehicle) or chemogenetic (CNO) chemogenetic stimulation (n=3 mice/group, two-sided unpaired t-test, p<0.01).”
Quote in the paperNot a substantial claim - Findingown data
Dark period energy expenditure normalized to body mass did not differ significantly between mice with chemogenetic AP GLP1R activation and those with NTS GLP1R activation.
“Dark period energy expenditure normalized to body mass by ANCOVA in mice with chemogenetic APGLP1R (blue) or NTSGLP1R (green) neuron activation (n=11 mice/group, ANCOVA, p=ns).”
Quote in the paperNot a substantial claim - Interpretationown data
NTS GLP1R→PVH neurons are potential neural targets for producing satiety without aversion.
“Overall, these data highlight NTSGLP1R→PVH neurons as potential neural targets for satiety without aversion.”
Quote in the paperSubstantial claim - Premisecitation
PVH MC4R neurons mediate satiety.
“PVHMC4R neurons mediate satiety31–33”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [31] Li, M. M. et al. The paraventricular hypothalamus regulates satiety and prevents obesity via two genetically distinct circuits. Neuron 102, 653–667 (2019). source
Not checked in the free run.
- cites [32] Zhang, S. X. et al. Competition between stochastic neuropeptide signals calibrates the rate of satiation. Preprint at bioRxiv https://doi.org/10.1101/2023.07.11.548551 (2023). source
Not checked in the free run.
- cites [33] Fenselau, H. et al. A rapidly acting glutamatergic ARC→PVH satiety circuit postsynaptically regulated by α-MSH. Nat. Neurosci. 20, 42–51 (2017). source
Not checked in the free run.
- Interpretationown data
Hindbrain GLP1R neurons are a critical site of action for GLP1-based obesity therapeutics.
“Here, we demonstrate that hindbrain GLP1R neurons are a critical site of action for GLP1-based obesity therapeutics”
Quote in the paperSubstantial claim- Rests on an assumption: The necessity of each drug-accessible GLP1R neural population for the anorexic and weight-loss effects of obesity therapeutics had not been systematically tested.
- Interpretationown data
The anorexic effect of GLP1-based obesity drugs remains intact even when the aversion pathway is inhibited.
“These data demonstrate that the anorexic effect of GLP1-based obesity drugs remains intact even when the aversion pathway is inhibited”
Quote in the paperSubstantial claim- Rests on an assumption: It is unknown whether GLP1 drug-induced nausea and anorexia are intrinsically linked as a mechanism for food intake suppression and weight loss.
- Study design and conductown data
Viral manipulations selectively ablated DVC, ARC, or NG GLP1R neurons without influencing the other GLP1R populations.
“These manipulations selectively ablated DVC, ARC, or NG GLP1R neurons without influencing the other GLP1R populations”
Quote in the paperSubstantial claim - Interpretationcitation
The findings do not rule out smaller contributions of the hypothalamus or other brain regions to the effects of GLP1-based obesity drugs.
“our findings do not rule out potential smaller contributions of the hypothalamus or other brain regions to the effects of GLP1-based obesity drugs”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [10] Gabery, S. et al. Semaglutide lowers body weight in rodents via distributed neural pathways. JCI Insight 5, https://doi.org/10.1172/jci.insight.133429 (2020). source
Not checked in the free run.
- cites [44] Secher, A. et al. The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss. J. Clin. Invest. 124, 4473–4488 (2014). source
Not checked in the free run.
- cites [48] Webster, A. N. et al. Molecular connectomics reveals a glucagon-like peptide 1 sensitive neural circuit for satiety. Preprint at bioRxiv https://doi.org/10.1101/2023.10.31.564990 (2023). source
Not checked in the free run.
- Interpretationown data
Distinct projections, AP GLP1R→lPBN and NTS GLP1R→PVH, mediate behaviorally distinct anorexic effects.
“Our dissection of the neural circuitry mediating the satiety and aversion effects of GLP1-based obesity drugs demonstrates that distinct projections – APGLP1R→lPBN and NTSGLP1R→PVH neurons – mediate behaviourally-distinct anorexic effects.”
Quote in the paperSubstantial claim - Interpretationown data
DVCGLP1R neurons are required for the food intake suppression caused by GLP1-based obesity drugs.
“DVCGLP1R neurons are required for the food intake suppression and weight loss effects of GLP1-based obesity drugs.”
Quote in the paperSubstantial claim - Interpretationreasoning
Functionally dissociable neural circuits mediate different effects of the same drug.
“this study demonstrates that functionally dissociable neural circuits mediate different effects of the same drug.”
Quote in the paperSubstantial claim - Study design and conductown data
The AAV2.2 strategy enabled expression in AP or NTS neurons without spread into neighboring regions.
“This strategy enabled expression in AP or NTS neurons without spread into neighbouring regions”
Quote in the paperSubstantial claim - Interpretationown data
Consistency in proportional AP and NTS GLP1R neural responses to stimuli across mice supports biased tuning of NTS GLP1R neurons toward nutritive over aversive stimuli.
“Nonetheless, the consistency in proportional APGLP1R and NTSGLP1R neural responses to stimuli across mice lend support to the biased tuning of NTSGLP1R neurons to nutritive over aversive stimuli.”
Quote in the paperSubstantial claim- Rests on an assumption: Ensure administered intraduodenally is a nutritive stimulus.
- Rests on an assumption: Lithium chloride administered intravenously is an aversive or nauseogenic stimulus.
- Interpretationreasoning
The intake-suppressive effects of the AP GLP1R→lPBN and NTS GLP1R→PVH projections are not additive.
“the finding that obesity drugs still suppress food intake, even in the absence of the aversion pathway emerging from APGLP1R neurons, suggests that the intake-suppressive effects of these projections are not additive.”
Quote in the paperSubstantial claim - Interpretationown data
DVCGLP1R neurons are required for the weight loss caused by GLP1-based obesity drugs.
“DVCGLP1R neurons are required for the food intake suppression and weight loss effects of GLP1-based obesity drugs.”
Quote in the paperSubstantial claim - Interpretationown data
DVCGLP1R neuron activation suppresses food intake.
“DVCGLP1R neuron activation suppresses food intake and energy expenditure.”
Quote in the paperSubstantial claim - Premisecitation
Hunger-sensitive AgRP neurons project to both the lPBN and PVH to modulate feeding behavior.
“hunger-sensitive AgRP neurons project to both the lPBN and PVH to modulate feeding behaviour55,56.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [55] Atasoy, D., Betley, J. N., Su, H. H. & Sternson, S. M. Deconstruction of a neural circuit for hunger. Nature 488, 172–177 (2012). source
Not checked in the free run.
- cites [56] Wu, Q., Boyle, M. P. & Palmiter, R. D. Loss of GABAergic signaling by AgRP neurons to the parabrachial nucleus leads to starvation. Cell 137, 1225–1234 (2009). source
Not checked in the free run.
- Interpretationown data
Obesity drugs remain effective at inducing satiety even when aversion circuitry is inhibited.
“we demonstrate that obesity drugs remain effective at inducing satiety even when aversion circuitry is inhibited.”
Quote in the paperSubstantial claim- Rests on an assumption: It is unknown whether GLP1 drug-induced nausea and anorexia are intrinsically linked as a mechanism for food intake suppression and weight loss.
- Interpretationown data
Key drug-accessible GLP1R populations outside the hindbrain, including vagal afferents and the hypothalamus, are dispensable for the therapeutic effects of GLP1-based obesity drugs.
“our data suggest that key drug-accessible GLP1R populations outside of the hindbrain (including vagal afferents and the hypothalamus45) are dispensable for their therapeutic effects”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [45] Burmeister, M. A. et al. The hypothalamic glucagon-like peptide 1 receptor Is sufficient but not necessary for the regulation of energy balance and glucose homeostasis in mice. Diabetes 66, 372–384 (2017). source
Not checked in the free run.
- Interpretationcitation
One or both DVC GLP1R projections likely engage motivation or reward circuitry.
“it is also likely that one or both of these DVCGLP1R projections ultimately engages motivation/reward circuitry.”
Quote in the paperNot a substantial claim - Interpretationown data
DVCGLP1R neuron activation suppresses energy expenditure.
“DVCGLP1R neuron activation suppresses food intake and energy expenditure.”
Quote in the paperNot a substantial claim - Study design and conductown data
Viral expression was specific to GLP1R neurons, as confirmed by in situ hybridization.
“Viral expression specifically in GLP1R neurons was validated using in situ hybridization (Extended Data Fig. 1a).”
Quote in the paperSubstantial claim - Interpretationreasoning
The mixed nature of the physiological responses is at least partly due to the mixed nature of the stimuli.
“we believe that the mixed nature of the physiological responses is at least in part due to the mixed nature of the stimuli”
Quote in the paperNot a substantial claim
- May combine two claims. 46
- The quote only partly states this claim. 3
- Classified as probably not a substantial claim. 23
May combine two claims.
Findingown dataAP and NTS GLP1R neuron tuning to nutritive and aversive stimuli was not absolute; their physiological responses were mixed.
“while APGLP1R neurons generally had greater responses to aversive stimuli and NTSGLP1R neurons had greater responses to nutritive stimuli, this neural tuning was not absolute”
Quote in the paperSubstantial claim- Rests on an assumption: Ensure administered intraduodenally is a nutritive stimulus.
- Rests on an assumption: Lithium chloride administered intravenously is an aversive or nauseogenic stimulus.
May combine two claims.
Findingown dataOptogenetic activation of AP GLP1R→lPBN neurons, but not NTS GLP1R→PVH neurons, reduced time spent in the stimulated environment in a real-time place avoidance assay.
“Optogenetic activation of APGLP1R→lPBN neurons, but not NTSGLP1R→PVH neurons, significantly reduced time spent in the environment where mice received stimulation”
Quote in the paperSubstantial claimThe quote only partly states this claim.
Findingown dataAmong drug-accessible GLP1R populations, only hindbrain DVC GLP1R neurons are necessary for the efficacy of GLP1-based obesity drugs.
“Systematic investigation across drug-accessible GLP1R populations revealed that only hindbrain neurons are required for the efficacy of GLP1-based obesity drugs.”
- Also stated in: § Obesity drugs act on hindbrain GLP1R neurons · boosted
“demonstrating the necessity of DVCGLP1R neurons for the efficacy of this obesity drug”
Quote in the paperSubstantial claim- Rests on an assumption: The necessity of each drug-accessible GLP1R neural population for the anorexic and weight-loss effects of obesity therapeutics had not been systematically tested.
- Also stated in: § Obesity drugs act on hindbrain GLP1R neurons · boosted
May combine two claims.
Findingown dataReanalysis of three single-cell/nucleus RNA sequencing datasets showed that AP and NTS GLP1R neurons are mixed excitatory and inhibitory populations, with a greater proportion of NTS GLP1R neurons being excitatory.
“we combined and re-analyzed three existing single cell/nucleus RNA sequencing datasets13,16,17 to determine that APGLP1R and NTSGLP1R neurons are mixed excitatory and inhibitory populations, with a greater proportion of NTSGLP1R neurons being excitatory”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [13] Zhang, C. et al. Area postrema cell types that mediate nausea-associated behaviors. Neuron 109, 461–472 (2021). source
Not checked in the free run.
- cites [16] Ludwig, M. Q. et al. A genetic map of the mouse dorsal vagal complex and its role in obesity. Nat. Metab. 3, 530–545 (2021). source
Not checked in the free run.
- cites [17] Adriaenssens, A. et al. Hypothalamic and brainstem glucose-dependent insulinotropic polypeptide receptor neurons employ distinct mechanisms to affect feeding. 8, https://doi.org/10.1172/jci.insight.164921 (2023). source
Not checked in the free run.
May combine two claims.
Findingown dataOptogenetic activation of AP GLP1R→lPBN, but not NTS GLP1R→PVH, projections reduced hedonic and increased aversive real-time taste reactivity.
“optogenetic activation of APGLP1R→lPBN, but not NTSGLP1R→PVH, projections reduced hedonic and increased aversive real-time taste reactivity”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataMore AP GLP1R neurons were activated by aversive cinacalcet, whereas more NTS GLP1R neurons were activated by nutritive Ensure.
“Further, more APGLP1R neurons were activated by the aversive stimulus (cinacalcet), whereas more NTSGLP1R neurons were activated by nutrients (Ensure)”
Quote in the paperSubstantial claim- Rests on an assumption: Ensure administered intraduodenally is a nutritive stimulus.
- Rests on an assumption: Lithium chloride administered intravenously is an aversive or nauseogenic stimulus.
May combine two claims.
Findingown dataAblation of ARC or NG GLP1R neurons did not block food intake suppression by exendin-4 or semaglutide.
“but not the populations in the ARC or NG, completely blocked food intake suppression by both exendin-4”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataSemaglutide significantly activated both AP and NTS GLP1R neurons compared with vehicle.
“Both APGLP1R and NTSGLP1R neurons were significantly activated by semaglutide in comparison to vehicle administration”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataNeither AP nor NTS GLP1R deletion affected exendin-4- or semaglutide-induced anorexia.
“Neither APGLP1R nor NTSGLP1R deletion affected exendin-4 or semaglutide-induced anorexia”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataAP GLP1R neuron activation, but not NTS GLP1R neuron activation, was sufficient to condition a CFA.
“Similarly, APGLP1R neuron13, but not NTSGLP1R neuron, activation was sufficient to condition a CFA”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataAAV2.2 EYFP tracing showed axon terminals in the lPBN of AP GLP1R-injected mice and in the PVH of NTS GLP1R-injected mice, with virtually no collateralization.
“This analysis revealed axon terminals in the lPBN of APGLP1R-injected mice, and axon terminals in the PVH of NTSGLP1R-injected mice, with virtually no collateralization”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataChemogenetic activation of DVC GLP1R neurons paired with a novel flavor reduced conditioned hedonic responses and increased conditioned aversive taste reactivity.
“After pairing, mice displayed fewer conditioned hedonic responses and increased conditioned aversive responses compared to control mice”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataOnly activation of AP GLP1R neurons, not NTS GLP1R neurons, reduced hedonic and increased aversive taste reactivity.
“Strikingly, only activation of APGLP1R neurons, and not NTSGLP1R neurons, reduced hedonic and increased aversive taste reactivity responses”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataActivation of NTS GLP1R neurons increased inter-meal interval but did not change meal size, indicating increased satiety.
“Activation of NTSGLP1R neurons increased inter-meal interval (Fig. 3i) but had no effect on meal size (Extended Data Fig. 8g), indicating that NTSGLP1R neurons increase satiety.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataAlternative motion correction methods did not change the calcium imaging results or conclusions.
“While these corrections did not influence our results or conclusions, they may be necessary for those analyzing frames with substantial uniform or non-uniform distortions, especially for preparations with ROIs along image edges.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataDVC GLP1R neurons form at least two subpopulations that are activated by either nutritive or aversive stimuli and are much less likely to be activated by both.
“we also demonstrate that DVCGLP1R neurons form at least two subpopulations that are activated by either nutritive or aversive stimuli (and are much less likely to be activated by both).”
Quote in the paperSubstantial claim- Rests on an assumption: Ensure administered intraduodenally is a nutritive stimulus.
- Rests on an assumption: Lithium chloride administered intravenously is an aversive or nauseogenic stimulus.
May combine two claims. The quote only partly states this claim.
Findingown dataExendin-4 reduced food intake in fasted control, ARC-ablated, and NG-ablated mice, but not in DVC-ablated mice.
“(d) Food intake following IP injection of saline or exendin-4 in fasted control or GLP1R-ablated mice (n=8–14 mice/group, two-way repeated measures ANOVAs, all ps<0.01 except DVC where p=ns).”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataDark period energy expenditure normalized to lean mass did not significantly differ between high-fat diet-fed control mice and mice with chronic NaChBac-mediated DVCGLP1R neuron activation (p=0.06).
“(f) Dark period energy expenditure normalized to lean mass by ANCOVA in high-fat diet-fed control mice or mice with chronic NaChBac-mediated DVCGLP1R neuron activation (n=7–8 mice/group, ANCOVA, p=0.06).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataGLP1R neurons in the dorsal vagal complex project densely to the NTS but not to the AP.
“Images depict the dense GLP1R projection into the NTS but not into the AP.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataEnsure administration increased average z-scored activity in both AP and NTS GLP1R neurons relative to saline.
“Average z-scored activity responses in APGLP1R neurons (blue) and NTSGLP1R neurons (green) to saline or Ensure administration (n=6 mice, two-way ANOVA, AP: saline vs Ensure: p<0.01, NTS: saline vs. Ensure p<0.001).”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Findingown dataQuinine concentration significantly affected composite aversive taste reactivity scores and individual aversive behaviours.
“Composite score (e, n=5–10 mice/group, one-way ANOVA, all ps<0.01) and individual behaviours (f, 5–10 mice/group, two-way ANOVA, all ps<0.05) for aversive taste reactivity responses to quinine concentrations (0, 2.4, 4 mM).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataChemogenetic activation of AP GLP1R neurons changed hedonic taste reactivity behaviours after conditioning, while activation of NTS GLP1R neurons did not.
“Individual hedonic taste reactivity behaviours at baseline and after conditioning with chemogenetic APGLP1R (l, n=8 mice, two-way ANOVA, RMM baseline vs. conditioned p<0.001) or NTSGLP1R (m, n=5 mice, two-way ANOVA, all ps=ns) neuron activation.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataChemogenetic activation of AP GLP1R neurons reduced meal size in fasted mice, whereas activation of NTS GLP1R neurons did not.
“Meal size in fasted mice following chemogenetic activation of APGLP1R or NTSGLP1R neurons (n=10–11 mice/group, two-way ANOVA, APGLP1R-hM3Dq vehicle vs. CNO: p<0.001, NTSGLP1R-hM3Dq vehicle vs. CNO: p=ns).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataSemaglutide induced conditioned flavour avoidance in WT mice but not in DVC GLP1R-deleted mice.
“Intake of flavour paired with semaglutide (CS+) in control (WT) or DVC GLP1R-deleted (Glp1rfl/fl) mice before (baseline) and after conditioning (n=6–8 mice/group, two-way ANOVA, WT baseline vs. conditioned: p<0.001, Glp1rfl/fl baseline vs. conditioned: p=ns).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataChemogenetic activation of AP GLP1R neurons changed aversive taste reactivity behaviours after conditioning, while activation of NTS GLP1R neurons did not.
“Individual aversive taste reactivity behaviours at baseline and after conditioning with chemogenetic APGLP1R (n, n=8 mice, two-way ANOVA, CR baseline vs. conditioned: p<0.001) or NTSGLP1R (o, n=5 mice, two-way ANOVA, all ps=ns) neuron activation.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataOptogenetic stimulation of APGLP1R→lPBN, but not NTSGLP1R→PVH, altered aversive taste reactivity behaviours.
“Individual aversive taste reactivity behaviours at baseline (pre-stimulation) and during optogenetic stimulation of APGLP1R→lPBN (m, n=6 mice, two-way ANOVA, CR no stim vs. stim: p<0.001) or NTSGLP1R→PVH (n, n=6 mice, two-way ANOVA, all ps=ns) neurons.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Findingown dataQuinine concentration significantly affected composite hedonic taste reactivity scores and individual hedonic behaviours.
“Composite score (c, n=5–10 mice/group, one-way ANOVA, all ps<0.05) and individual behaviours (d, n=5–10 mice/group, two-way ANOVA, all ps<0.001) for hedonic taste reactivity responses to quinine concentrations (0, 2.4, 4 mM).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataOptogenetic activation of APGLP1R→lPBN or NTSGLP1R→PVH neurons did not affect 1-h food intake in control mice expressing EYFP.
“Food intake (1 h) in control mice expressing EYFP in APGLP1R→lPBN (a, n=6 mice, paired t-test, p=ns) and NTSGLP1R→PVH (b, n=5 mice, two-sided paired t-test, p=ns) neurons.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataOptogenetic activation of APGLP1R→lPBN or NTSGLP1R→PVH did not induce real-time place avoidance in fasted mice expressing ChR2.
“Time spent in stimulation zone during real-time place avoidance assay in fasted mice expressing ChR2 in APGLP1R→lPBN (i, n=11 mice, two-way ANOVA, all ps=ns) or NTSGLP1R→PVH (j, n=7 mice, two-way ANOVA, all ps=ns) neurons.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataThe mean time to semaglutide-induced activation did not differ between AP and NTS GLP1R neurons.
“Mean time to semaglutide-induced activation in APGLP1R and NTSGLP1R neurons depicted in h (n=5 mice, two-sided unpaired t-test, p=ns).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataOptogenetic activation of APGLP1R→lPBN, but not NTSGLP1R→PVH, induced real-time place avoidance in ad libitum-fed mice expressing ChR2.
“Time spent in stimulation zone during real-time place avoidance assay in ad libitum-fed mice expressing ChR2 in APGLP1R→lPBN (g, n=10–11 mice/group, two-way ANOVA, Trials 2&3 no stim vs. stim: ps<0.05) or NTSGLP1R→PVH (h, n=7 mice, two-way ANOVA, all ps=ns).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe number of AP GLP1R neurons expressing hM3Dq correlates with avoidance behaviour, while the number of NTS GLP1R neurons expressing hM3Dq does not.
“Number of APGLP1R, but not NTSGLP1R, neurons expressing chemogenetic receptors correlates with avoidance behaviour.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIn ad libitum-fed control mice expressing EYFP, optogenetic stimulation of APGLP1R→lPBN or NTSGLP1R→PVH did not affect time spent in the stimulation zone during a real-time place avoidance assay.
“Time spent in stimulation zone during real-time place avoidance assay in ad libitum-fed control mice expressing EYFP in APGLP1R→lPBN (c, n=5–6 mice/group, two-way ANOVA, all ps=ns) or NTSGLP1R→PVH (d, n=5 mice, two-way ANOVA, all ps=ns) neurons.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataAP and NTS GLP1R neurons are generally distinct from other hindbrain cell types and mediate aversion and satiety, respectively.
“Together with physiological and behavioural results, these data indicate that APGLP1R and NTSGLP1R neurons are generally distinct from other hindbrain cell types and mediate aversion and satiety responses, respectively.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataThe NTS GLP1R→PVH circuit suppresses feeding without inducing aversion.
“highlighting a NTSGLP1R→PVH circuit that suppresses feeding without inducing aversion.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataDVC GLP1R neuron activation suppresses food intake through increased satiety, indicated by longer inter-meal intervals and unchanged meal size, rather than through changes in energy expenditure.
“These effects were mediated by suppression of food intake due to increased satiety – indicated by increased inter-meal interval and no change in meal size”
- Also stated in: § Obesity drugs act on hindbrain GLP1R neurons · plain
“and not by changes in energy expenditure”
Quote in the paperSubstantial claim- Also stated in: § Obesity drugs act on hindbrain GLP1R neurons · plain
May combine two claims.
Interpretationown dataTwo anatomically and functionally distinct GLP1R projections arising from the AP and NTS drive aversion and satiety, respectively.
“reveal two anatomically and functionally distinct GLP1R projections – arising from the AP and the NTS – that drive aversion and satiety, respectively.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationGLP1R agonist obesity drugs produce aversive effects such as nausea and vomiting, and these effects may contribute to their therapeutic efficacy.
“The most successful obesity therapeutics – glucagon-like peptide-1 receptor (GLP1R) agonists – cause aversive responses such as nausea and vomiting1,2, effects which may contribute to their efficacy.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [1] Wadden, T. A. et al. Effect of subcutaneous semaglutide vs placebo as an adjunct to intensive behavioral therapy on body weight in adults with overweight or obesity: The STEP 3 Randomized Clinical Trial. JAMA 325, 1403–1413 (2021). source
Not checked in the free run.
- cites [2] Wilding, J. P. H. et al. Once-weekly semaglutide in adults with overweight or obesity. N. Engl. J. Med. 384, 989–1002 (2021). source
Not checked in the free run.
May combine two claims.
InterpretationreasoningAP GLP1R and NTS GLP1R neurons send projections to largely different downstream brain regions and cell types, potentially mediating distinct anorexic behaviors.
“Therefore, APGLP1R and NTSGLP1R neurons send projections to largely different downstream brain regions and cell types to potentially mediate distinct anorexic behaviours.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationlPBN CGRP neurons suppress food intake and drive aversion.
“lPBNCGRP neurons suppress food intake and drive aversion28–30”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [28] Carter, M. E., Han, S. & Palmiter, R. D. Parabrachial calcitonin gene-related peptide neurons mediate conditioned taste aversion. J. Neurosci. 35, 4582–4586 (2015). source
Not checked in the free run.
- cites [29] Campos, C. A., Bowen, A. J., Schwartz, M. W. & Palmiter, R. D. Parabrachial CGRP neurons control meal termination. Cell Metab 23, 811–820 (2016). source
Not checked in the free run.
- cites [30] Carter, M. E., Soden, M. E., Zweifel, L. S. & Palmiter, R. D. Genetic identification of a neural circuit that suppresses appetite. Nature 503, 111–114 (2013). source
Not checked in the free run.
May combine two claims.
Interpretationown dataNTS GLP1R neurons inhibit food intake and body weight without inducing aversion.
“These data highlight NTSGLP1R neurons as a population that inhibits food intake and body weight without inducing aversion.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenInvestigators collecting or analyzing data were blinded to experimental conditions.
“Investigators collecting (e.g, performing behavioural measurements) or analyzing (e.g., counting neurons) data were blinded to experimental conditions.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenMice showing excessive food grinding were excluded from all analyses.
“Mice with excessive food grinding behaviours (<5% of all mice tested) were excluded from all analyses.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationThe adverse gastrointestinal side effects of GLP1-based obesity drugs are more severe at the start of treatment and tend to decrease over time.
“Clinically, the adverse gastrointestinal side effects of GLP1-based obesity drugs are more severe at the start of treatment and tend to decrease over time54.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [54] Shu, Y. et al. Gastrointestinal adverse events associated with semaglutide: a pharmacovigilance study based on FDA adverse event reporting system. Front. Public Health 10, 996179 (2022). source
Not checked in the free run.
Probably not a substantial claim: may not pass S1 (asserted), S3 (load-bearing), S4 (based).
Study design and conductown dataBefore calcium activity analysis, AP and NTS boundaries were drawn using anatomical landmarks to prevent bias.
“Prior to analysis of calcium activity (to prevent any bias), boundaries between the AP and NTS were drawn for each z plane using (1) the differential density of GLP1R neurons in AP vs. NTS which creates a natural boundary”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing).
InterpretationcitationBecause nausea and vomiting are side effects of many treatments, the concept of dissociable circuits could be applied to investigate other therapeutics.
“Because nausea and vomiting are side effects of thousands of treatments for human disease60, this concept could be applied to investigate other therapeutics”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [60] Wickham, R. J. Nausea and vomiting: a palliative care imperative. Curr. Oncol. Rep. 22, 1 (2020). source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenMice that did not eat during the 4-6 h post-CNO period were excluded from inter-meal interval analyses.
“Mice that did not eat in this time period (n=2 across all experiments) were excluded from inter-meal-interval analyses.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationNTS serotonin 2C receptors are both necessary and sufficient for the anorexic effects of lorcaserin.
“NTS serotonin 2C receptors (5HT2CR) are both necessary and sufficient for the anorexic effects of a previously-used obesity drug, lorcaserin47.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [47] D’Agostino, G. et al. Nucleus of the solitary tract serotonin 5-HT2C receptors modulate food intake. Cell Metab. 28, 619–630 (2018). source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenTechnical constraints, including imaging under anesthesia and applying only one trial each of nutritive and aversive stimuli within the same imaging session, limit interpretations of the results.
“We also note that technical constraints, such as imaging under anesthesia and applying only one trial each of nutritive and aversive stimuli within the same imaging session, limit interpretations of results.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
PremisecitationDTA has previously been used to ablate nodose ganglion neurons.
“because DTA has been previously used to ablate NG neurons67”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [67] Ghidewon, M. et al. Growth differentiation factor 15 (GDF15) and semaglutide inhibit food intake and body weight through largely distinct, additive mechanisms. Diabetes Obes. Metab. 24, 1010–1020 (2022). source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataThere were no significant body weight differences between groups at baseline.
“Although there were no significant body weight differences between groups at baseline”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationNTS CCK neurons project to the lPBN and PVH; NTS CCK→lPBN projections cause negative valence, whereas NTS CCK→PVH projections do not.
“NTSCCK neurons also project to the lPBN and PVH, and NTSCCK→lPBN projections cause negative valence but NTSCCK→PVH projections do not49–51.”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [49] D’Agostino, G. et al. Appetite controlled by a cholecystokinin nucleus of the solitary tract to hypothalamus neurocircuit., eLife 5, e12225 (2016). source
Not checked in the free run.
- cites [50] Roman, C. W., Sloat, S. R. & Palmiter, R. D. A tale of two circuits: CCKNTS neuron stimulation controls appetite and induces opposing motivational states by projections to distinct brain regions. Neuroscience 358, 316–324 (2017). source
Not checked in the free run.
- cites [51] Cheng, W. et al. Calcitonin receptor neurons in the mouse nucleus tractus solitarius control energy balance via the non-aversive suppression of feeding. Cell Metab. 31, 301–312 (2020). source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationFluorescently tagged semaglutide binds in both the AP and the NTS.
“Although fluorescently-tagged semaglutide binds in both the AP and the NTS10”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [10] Gabery, S. et al. Semaglutide lowers body weight in rodents via distributed neural pathways. JCI Insight 5, https://doi.org/10.1172/jci.insight.133429 (2020). source
Not checked in the free run.
May combine two claims.
Study design and conductown dataBoth Casp3 and DTA methods effectively ablated the targeted GLP1R neurons.
“We verified that both techniques (Casp3 and DTA) effectively ablated our neurons of interest (Extended Data Fig. 1b, c).”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataAll sample sizes reported in the manuscript refer to biological replicates.
“All ns reported throughout the manuscript are biological replicates.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims. The quote only partly states this claim.
Study design and conductown dataExclusions from data were limited to mice with significant spillage, unexpected illness or euthanasia, and no food intake for meal pattern analyses.
“There were no exclusions from the data except for the following: For food intake measurements, mice with significant spillage were excluded from analysis”
Quote in the paperNot a substantial claimMay combine two claims.
Study design and conductown dataNo significant sex differences were observed across all studies except one experiment, so results for males and females were combined.
“Except for one experiment (Extended Data Fig. 1f) which had a smaller but still significant effect in female compared to male mice, we did not observe any significant sex differences across all studies and therefore we combined results for males and females.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationGLP1R signaling reduces motivational aspects of feeding and other behaviors such as alcohol and drug intake.
“given the role of GLP1R signaling in reducing motivational aspects of feeding and other behaviours such as alcohol and drug intake38,57–59”
Quote in the paperNot a substantial claim0 of 4 sources checked- cites [38] Alhadeff, A. L. & Grill, H. J. Hindbrain nucleus tractus solitarius glucagon-like peptide-1 receptor signaling reduces appetitive and motivational aspects of feeding. Am. J. Physiol. Regul. Integr. Comp. Physiol. 307, R465–R470 (2014). source
Not checked in the free run.
- cites [57] Egecioglu, E. et al. The glucagon-like peptide 1 analogue Exendin-4 attenuates alcohol mediated behaviors in rodents. Psychoneuroendocrinology 38, 1259–1270 (2013). source
Not checked in the free run.
- cites [58] Tuesta, L. M. et al. GLP-1 acts on habenular avoidance circuits to control nicotine intake. Nat. Neurosci. 20, 708–716 (2017). source
Not checked in the free run.
- cites [59] Schmidt, H. D. et al. Glucagon-like peptide-1 receptor activation in the ventral tegmental area decreases the reinforcing efficacy of cocaine. Neuropsychopharmacology 41, 1917–1928 (2016). source
Not checked in the free run.
Classified as probably not a substantial claim.
Study design and conductown dataMice lacking viral expression or with expression outside the target region were excluded from analyses after post-mortem verification.
“Where appropriate, viral expression was verified post-mortem; any mouse that did not express virus or expressed virus outside of the target region was excluded from analyses.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenFor between-subject analyses, mice were randomly assigned to experimental condition.
“For between-subject analyses, mice were randomly assigned to experimental condition.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataPower analyses were run to ensure that sample sizes were sufficient to determine significant differences between groups.
“Power analyses were run [beta = 0.2 (80% power), alpha =0.05] with effect sizes based on pilot studies (n=3–6) to ensure that sample sizes (number of mice for behavioural studies, number of neurons for physiological/anatomical studies) were sufficient to determine significant differences between groups.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductown dataAlternative motion correction strategies did not significantly change the proportions of activated neurons or individual calcium traces in this imaging setup.
“Although these alternate motion correction strategies did not significantly change our data, we note for readers that some imaging preparations (especially those that have more ROIs around the edges of frames) may require such strategies.”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationown dataIndividual AP and NTS GLP1R neurons are specialized, with most biased toward nutritive or aversive stimuli and less overlap than expected by chance.
“That the probability of a cell being activated by both stimuli is generally lower than the product of individual probabilities suggests a level of specialization of individual cells where most are biased toward nutritive or aversive stimuli, with less overlap than would be expected by chance.”
Quote in the paperSubstantial claim
The paper relies on this without support.
The necessity of each drug-accessible GLP1R neural population for the anorexic and weight-loss effects of obesity therapeutics had not been systematically tested.
“However, the necessity of each of these neural populations (Fig. 1a) in the anorexic and weight loss effects of obesity therapeutics has not been systematically tested.”
The paper relies on this without support.
Whether nausea and satiety arise from similar or different neural circuits remains unclear.
“whether nausea and satiety arise from similar or different neural circuits remains unclear.”
The paper relies on this without support.
Dissociable GLP1R-mediated mechanisms for satiety and nausea or aversion remain unknown.
“this depends on the existence of dissociable GLP1R-mediated mechanisms for satiety and nausea/aversion, which remain unknown.”
The paper relies on this without support.
It is unknown whether GLP1 drug-induced nausea and anorexia are intrinsically linked as a mechanism for food intake suppression and weight loss.
“it is unknown whether these features are intrinsically linked as a mechanism for food intake suppression and weight loss.”
The paper relies on this without support.
Ensure administered intraduodenally is a nutritive stimulus.
“responsivity to nutrients [Ensure, administered intraduodenally (ID)]”
The paper relies on this without support.
Lithium chloride administered intravenously is an aversive or nauseogenic stimulus.
“or nauseogenic/aversive stimuli [cinacalcet or lithium chloride (LiCl), both administered IV]”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Recent mechanistic studies, primarily in rodents, have identified sites of direct action putatively mediating the effects of GLP-1-based anti-obesity medications on eating and body weight, including the area postrema and nucleus tractus solitarius, locus coeruleus, hypothalamic arcuate and dorsomedial nuclei, and lateral septal nucleus.
“Recent mechanistic studies, primarily conducted in rodents, have identified a number of sites of direct action putatively mediating the effects of GLP-1-based AOMs on eating and body weight, including the area postrema and nucleus tractus solitarius (47‐49), locus coeruleus (50), hypothalamic arcuate (51, 52) and dorsomedial nuclei (53), and the lateral septal nucleus (54).”
From GLP-1 and the Neurobiology of Eating Control: Recent Advances (2025) · cites this paper as [47]
GLP-1R-expressing neuron populations in the area postrema, and at least some of the nucleus tractus solitarius, are clearly activated by GLP-1RAs and appear to mediate at least some of the effects of these drugs on satiation, satiety, and nausea/malaise, likely by recruiting circuits which are endogenous targets of supraphysiological gut-derived GLP-1.
“GLP-1R-expressing neuron populations in the AP, and at least some of the NTS, are clearly activated by GLP-1RAs and appear to mediate at least some of the effects of these drugs on satiation, satiety, and nausea/malaise (47‐49), likely by recruiting circuits which are endogenous targets of (supraphysiological) gut-derived GLP-1.”
From GLP-1 and the Neurobiology of Eating Control: Recent Advances (2025) · cites this paper as [47]
The individual necessity of distinct GLP-1R neuron populations for the anorectic and weight loss effects of GLP-1RAs has now been claimed by multiple studies using various loss-of-function approaches in rodents.
“The individual necessity of distinct GLP-1R neuron populations for the anorectic and weight loss effects of GLP-1RAs has now been claimed by multiple studies using various loss-of-function approaches in rodents (47, 50‐54, 69).”
From GLP-1 and the Neurobiology of Eating Control: Recent Advances (2025) · cites this paper as [47]
A recent rodent study posited the area postrema and nucleus tractus solitarius as indispensable targets for the anorectic and weight loss effects of semaglutide, and that GLP-1R neurons in the area postrema, but not nucleus tractus solitarius, drive GLP-1RA-mediated nausea responses.
“Indeed, a recent rodent study has posited the AP and NTS as indispensable targets for the anorectic and weight loss effects of semaglutide, and that GLP-1R neurons in the AP, but not NTS, drive GLP-1RA-mediated nausea responses (47).”
From GLP-1 and the Neurobiology of Eating Control: Recent Advances (2025) · cites this paper as [47]
There are populations of GLP-1R neurons within the area postrema and nucleus tractus solitarius that facilitate nausea and satiation/satiety, likely through functionally discrete neurocircuits.
“Hence it appears that there are populations of GLP-1R neurons within the AP and NTS that facilitate nausea and satiation/satiety, likely through functionally discrete neurocircuits (47).”
From GLP-1 and the Neurobiology of Eating Control: Recent Advances (2025) · cites this paper as [47]
Cites
Integrated analysis of multimodal single-cell data
Hao, Y., Hao, S., Andersen-Nissen, E., Mauck, W. M., Zheng, S., Butler, A., Lee, M. J., Wilk, A. J., Darby, C., Zagar, M., et al. (2020) · doi:10.1101/2020.10.12.335331 · Cited by 15,508 · see citing works
Integrating single-cell transcriptomic data across different conditions, technologies, and species
Butler, A., Hoffman, P., Smibert, P., Papalexi, E., & Satija, R. (2018) · Nature Biotechnology · doi:10.1038/nbt.4096 · Cited by 13,174 · see citing works
Once-Weekly Semaglutide in Adults with Overweight or Obesity
Wilding, J. P. H., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., McGowan, B. M., Rosenstock, J., Tran, M. T. D., Wadden, T. A., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2032183 · Cited by 5,205 · see citing works
Cellpose: a generalist algorithm for cellular segmentation
Stringer, C., Wang, T., Michaelos, M., & Pachitariu, M. (2021) · Nature Methods · doi:10.1038/s41592-020-01018-x · Cited by 4,369 · see citing works
Tirzepatide Once Weekly for the Treatment of Obesity
Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., Wharton, S., Connery, L., Alves, B., Kiyosue, A., Zhang, S., Liu, B., Bunck, M. C., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2206038 · Cited by 3,838 · see citing works
Glucagon-like peptide 1 (GLP-1)
Müller, T. D., Finan, B., Bloom, S. R., D'Alessio, D., Drucker, D. J., Flatt, P. R., Fritsche, A., Gribble, F., Grill, H. J., Habener, J. F., et al. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.09.010 · Cited by 1,868 · see citing works
A toolbox of Cre-dependent optogenetic transgenic mice for light-induced activation and silencing
Madisen, L., Mao, T., Koch, H., Zhuo, J.-M., Berenyi, A., Fujisawa, S., Hsu, Y.-W. A., Garcia, A. J., Gu, X., Zanella, S., et al. (2012) · Nature Neuroscience · doi:10.1038/nn.3078 · Cited by 1,398 · see citing works
The taste reactivity test. I. Mimetic responses to gustatory stimuli in neurologically normal rats
Grill, H. J., & Norgren, R. (1978) · Brain Research · doi:10.1016/0006-8993(78)90568-1 · Cited by 1,203 · see citing works
Triple-Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial
Jastreboff, A. M., Kaplan, L. M., Frías, J. P., Wu, Q., Du, Y., Gurbuz, S., Coskun, T., Haupt, A., Milicevic, Z., & Hartman, M. L. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2301972 · Cited by 1,174 · see citing works
Wadden, T. A., Bailey, T. S., Billings, L. K., Davies, M., Frias, J. P., Koroleva, A., Lingvay, I., O’Neil, P. M., Rubino, D. M., Skovgaard, D., et al. (2021) · JAMA · doi:10.1001/jama.2021.1831 · Cited by 1,114 · see citing works
NoRMCorre: An online algorithm for piecewise rigid motion correction of calcium imaging data
Pnevmatikakis, E. A., & Giovannucci, A. (2017) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2017.07.031 · Cited by 1,038 · see citing works
Simultaneous Denoising, Deconvolution, and Demixing of Calcium Imaging Data
Pnevmatikakis, E. A., Soudry, D., Gao, Y., Machado, T. A., Merel, J., Pfau, D., Reardon, T. R., Mu, Y., Lacefield, C., Yang, W., et al. (2016) · Neuron · doi:10.1016/j.neuron.2015.11.037 · Cited by 1,035 · see citing works
Deconstruction of a neural circuit for hunger
Atasoy, D., Betley, J. N., Su, H. H., & Sternson, S. M. (2012) · Nature · doi:10.1038/nature11270 · Cited by 969 · see citing works
The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss
Secher, A., Jelsing, J., Baquero, A. F., Hecksher-Sørensen, J., Cowley, M. A., Dalbøge, L. S., Hansen, G., Grove, K. L., Pyke, C., Raun, K., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci75276 · Cited by 961 · see citing works
CaImAn an open source tool for scalable calcium imaging data analysis
Giovannucci, A., Friedrich, J., Gunn, P., Kalfon, J., Brown, B. L., Koay, S. A., Taxidis, J., Najafi, F., Gauthier, J., Zhou, P., et al. (2019) · eLife · doi:10.7554/elife.38173 · Cited by 827 · see citing works
Wyvell, C. L., & Berridge, K. C. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-21-08122.2000 · Cited by 764 · cited 1× · see citing works
“The composite score was calculated by summing all of the resulting measures 68,69 .”
Semaglutide lowers body weight in rodents via distributed neural pathways.
Gabery, S., Salinas, C. G., Paulsen, S. J., Ahnfelt-Rønne, J., Alanentalo, T., Baquero, A. F., Buckley, S. T., Farkas, E., Fekete, C., Frederiksen, K. S., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.133429 · Cited by 717 · see citing works
Sensory neurons that detect stretch and nutrients in the digestive system
Williams, E. K., Chang, R. B., Strochlic, D. E., Umans, B. D., Lowell, B. B., & Liberles, S. D. (2016) · Cell · doi:10.1016/j.cell.2016.05.011 · Cited by 645 · see citing works
Genetic identification of a neural circuit that suppresses appetite
Carter, M. E., Soden, M. E., Zweifel, L. S., & Palmiter, R. D. (2013) · Nature · doi:10.1038/nature12596 · Cited by 587 · see citing works
A Prokaryotic Voltage-Gated Sodium Channel
Ren, D., Navarro, B., Xu, H., Yue, L., Shi, Q., & Clapham, D. E. (2001) · Science · doi:10.1126/science.1065635 · Cited by 508 · see citing works
Hindbrain Neurons as an Essential Hub in the Neuroanatomically Distributed Control of Energy Balance
Grill, H. J., & Hayes, M. R. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.06.015 · Cited by 483 · see citing works
Cork, S. C., Richards, J. E., Holt, M. K., Gribble, F. M., Reimann, F., & Trapp, S. (2015) · Molecular Metabolism · doi:10.1016/j.molmet.2015.07.008 · Cited by 478 · see citing works
Göke, R., Larsen, P. J., Mikkelsen, J. D., & Sheikh, S. P. (1995) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1995.tb00650.x · Cited by 474 · see citing works
Loss of GABAergic Signaling by AgRP Neurons to the Parabrachial Nucleus Leads to Starvation
Wu, Q., Boyle, M. P., & Palmiter, R. D. (2009) · Cell · doi:10.1016/j.cell.2009.04.022 · Cited by 465 · see citing works
Lindberg, J. S., Culleton, B. F., Wong, G., Borah, M. F., Clark, R. V., Shapiro, W. B., Roger, S. D., Husserl, F. E., Klassen, P., Guo, M. D., et al. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004060512 · Cited by 412 · see citing works
Neuronal GLP1R mediates liraglutide’s anorectic but not glucose-lowering effect
Sisley, S. R., Gutiérrez‐Aguilar, R., Scott, M. M., D’Alessio, D. A., Sandoval, D. A., & Seeley, R. J. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72434 · Cited by 394 · see citing works
Kanoski, S. E., Fortin, S. M., Arnold, M., Grill, H. J., & Hayes, M. R. (2011) · Endocrinology · doi:10.1210/en.2011-0174 · Cited by 347 · see citing works
The gut–brain axis mediates sugar preference
Tan, H.-E., Sisti, A. C., Jin, H., Vignovich, M., Villavicencio, M., Tsang, K. S., Goffer, Y., & Zuker, C. S. (2020) · Nature · doi:10.1038/s41586-020-2199-7 · Cited by 317 · see citing works
Rinaman, L. (2010) · Brain Research · doi:10.1016/j.brainres.2010.03.059 · Cited by 311 · see citing works
Watakabe, A., Ohtsuka, M., Kinoshita, M., Takaji, M., Isa, K., Mizukami, H., Ozawa, K., Isa, T., & Yamamori, T. (2015) · Neuroscience Research · doi:10.1016/j.neures.2014.09.002 · Cited by 303 · see citing works
Whole-brain mapping of the direct inputs and axonal projections of POMC and AgRP neurons
Wang, D., He, X., Zhao, Z., Feng, Q., Lin, R., Sun, Y., Ding, T., Xu, F., Luo, M., & Zhan, C. (2015) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2015.00040 · Cited by 298 · see citing works
Wilson, H., Chambers, A. P., Ryan, K. K., Li, B., Sandoval, D. A., Stoffers, D. A., Drucker, D. J., Pérez–Tilve, D., & Seeley, R. J. (2013) · Diabetes · doi:10.2337/db12-1498 · Cited by 286 · see citing works
Kanoski, S. E., Rupprecht, L. E., Fortin, S. M., De Jonghe, B. C., & Hayes, M. R. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.12.022 · Cited by 273 · see citing works
Pelchat, M. L., Grill, H. J., Rozin, P., & Jacobs, J. (1983) · Journal of comparative psychology · doi:10.1037/0735-7036.97.2.140 · Cited by 272 · see citing works
Knockdown of GLP-1 Receptors in Vagal Afferents Affects Normal Food Intake and Glycemia
Krieger, J.-P., Arnold, M., Pettersen, K. G., Lossel, P., Langhans, W., & Lee, S. J. (2016) · Diabetes · doi:10.2337/db15-0973 · Cited by 269 · see citing works
Area postrema cell types that mediate nausea-associated behaviors
Zhang, C., Kaye, J. A., Cai, Z., Wang, Y., Prescott, S. L., & Liberles, S. D. (2021) · Neuron · doi:10.1016/j.neuron.2020.11.010 · Cited by 263 · see citing works
Parabrachial CGRP Neurons Control Meal Termination
Campos, C. A., Bowen, A. J., Schwartz, M. W., & Palmiter, R. D. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.04.006 · Cited by 262 · see citing works
Hayes, M. R., Leichner, T. M., Zhao, S., Lee, G., Chowansky, A., Zimmer, D. J., Jonghe, B. C. D., Kanoski, S. E., Grill, H. J., & Bence, K. K. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.02.001 · Cited by 234 · see citing works
A rapidly acting glutamatergic ARC→PVH satiety circuit postsynaptically regulated by α-MSH
Fenselau, H., Campbell, J. N., Verstegen, A. M. J., Madara, J. C., Xu, J., Shah, B. P., Resch, J. M., Yang, Z., Mandelblat-Cerf, Y., Livneh, Y., et al. (2017) · Nature Neuroscience · doi:10.1038/nn.4442 · Cited by 233 · see citing works
A Neural Circuit for the Suppression of Pain by a Competing Need State
Alhadeff, A. L., Su, Z., Hernandez, E., Klima, M. L., Phillips, S. Z., Holland, R. A., Guo, C., Hantman, A. W., De Jonghe, B. C., & Betley, J. N. (2018) · Cell · doi:10.1016/j.cell.2018.02.057 · Cited by 218 · see citing works
Self-citationHayes, M. R., Skibicka, K. P., & Grill, H. J. (2008) · Endocrinology · doi:10.1210/en.2007-1743 · Cited by 214 · see citing works
The glucagon-like peptide 1 analogue Exendin-4 attenuates alcohol mediated behaviors in rodents
Egecioglu, E., Steensland, P., Fredriksson, I., Feltmann, K., Engel, J. A., & Jerlhag, E. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2012.11.009 · Cited by 207 · see citing works
GLP-1 acts on habenular avoidance circuits to control nicotine intake
Tuesta, L. M., Chen, Z., Duncan, A., Fowler, C. D., Ishikawa, M., Lee, B. R., Liu, X.-A., Lu, Q., Cameron, M., Hayes, M. R., et al. (2017) · Nature Neuroscience · doi:10.1038/nn.4540 · Cited by 200 · see citing works
Li, M. M., Madara, J. C., Steger, J. S., Krashes, M. J., Balthasar, N., Campbell, J. N., Resch, J. M., Conley, N. J., Garfield, A. S., & Lowell, B. B. (2019) · Neuron · doi:10.1016/j.neuron.2019.02.028 · Cited by 195 · see citing works
Appetite controlled by a cholecystokinin nucleus of the solitary tract to hypothalamus neurocircuit
D'Agostino, G., Lyons, D. J., Cristiano, C., Burke, L. K., Madara, J. C., Campbell, J. N., Garcia, A. P., Land, B. B., Lowell, B. B., Dileone, R. J., et al. (2016) · eLife · doi:10.7554/elife.12225 · Cited by 193 · see citing works
A genetic map of the mouse dorsal vagal complex and its role in obesity
Ludwig, M. Q., Cheng, W., Gordian, D., Lee, J., Paulsen, S. J., Hansen, S. N., Egerod, K. L., Barkholt, P., Rhodes, C. J., Secher, A., et al. (2021) · Nature Metabolism · doi:10.1038/s42255-021-00363-1 · Cited by 186 · see citing works
Parabrachial Calcitonin Gene-Related Peptide Neurons Mediate Conditioned Taste Aversion
Carter, M. E., Han, S., & Palmiter, R. D. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.3729-14.2015 · Cited by 180 · see citing works
Hypothalamic detection of macronutrients via multiple gut-brain pathways
Goldstein, N., McKnight, A. D., Carty, J. R. E., Arnold, M., Betley, J. N., & Alhadeff, A. L. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2020.12.018 · Cited by 176 · see citing works
Self-citationRole of the glucagon-like-peptide-1 receptor in the control of energy balance
Hayes, M. R., De Jonghe, B. C., & Kanoski, S. E. (2010) · Physiology & Behavior · doi:10.1016/j.physbeh.2010.02.029 · Cited by 173 · see citing works
A brainstem map for visceral sensations
Chen, R., Boettcher, J. C., Kaye, J. A., Gallori, C. E., & Liberles, S. D. (2022) · Nature · doi:10.1038/s41586-022-05139-5 · Cited by 172 · see citing works
Brainstem ADCYAP1+ neurons control multiple aspects of sickness behaviour
Ilanges, A., Shiao, R., Shaked, J. T., Luo, J., Yu, X., & Friedman, J. M. (2022) · Nature · doi:10.1038/s41586-022-05161-7 · Cited by 156 · see citing works
Nucleus of the Solitary Tract Serotonin 5-HT2C Receptors Modulate Food Intake
D'Agostino, G., Lyons, D., Cristiano, C., Lettieri, M., Olarte-Sanchez, C., Burke, L. K., Greenwald-Yarnell, M., Cansell, C., Doslikova, B., Georgescu, T., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.07.017 · Cited by 149 · see citing works
Schmidt, H. D., Mietlicki-Baase, E. G., Ige, K. Y., Maurer, J. J., Reiner, D. J., Zimmer, D. J., Van Nest, D. S., Guercio, L. A., Wimmer, M. E., Olivos, D. R., et al. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2015.362 · Cited by 148 · see citing works
Jensen, C. B., Pyke, C., Rasch, M. G., Dahl, A. B., Knudsen, L. B., & Secher, A. (2018) · Endocrinology · doi:10.1210/en.2017-00812 · Cited by 145 · see citing works
Shu, Y., He, X., Wu, P., Liu, Y., Ding, Y., & Zhang, Q. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.996179 · Cited by 145 · see citing works
Spector, A. C., Breslin, P. A. S., & Grill, H. J. (1988) · Behavioral Neuroscience · doi:10.1037//0735-7044.102.6.942 · Cited by 140 · see citing works
The gut-to-brain axis for toxin-induced defensive responses
Xie, Z., Zhang, X., Zhao, M., Huo, L., Huang, M., Li, D., Zhang, S., Cheng, X., Gu, H., Zhang, C., et al. (2022) · Cell · doi:10.1016/j.cell.2022.10.001 · Cited by 137 · see citing works
Burmeister, M. A., Ayala, J. E., Smouse, H., Landivar-Rocha, A., Brown, J. D., Drucker, D. J., Stoffers, D. A., Sandoval, D. A., Seeley, R. J., & Ayala, J. E. (2017) · Diabetes · doi:10.2337/db16-1102 · Cited by 136 · see citing works
Arterial Baroreceptors Sense Blood Pressure through Decorated Aortic Claws
Min, S., Chang, R. B., Prescott, S. L., Beeler, B., Joshi, N. R., Strochlic, D. E., & Liberles, S. D. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.10.040 · Cited by 134 · see citing works
Benzodiazepines, appetite, and taste palatability
Berridge, K. C., & Peciña, S. (1995) · Neuroscience & Biobehavioral Reviews · doi:10.1016/0149-7634(94)00026-w · Cited by 132 · see citing works
Fortin, S. M., Lipsky, R. K., Lhamo, R., Chen, J., Kim, E., Borner, T., Schmidt, H. D., & Hayes, M. R. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aay8071 · Cited by 127 · see citing works
Spector, A. C., Breslin, P. A. S., & Grill, H. J. (1988) · Behavioral Neuroscience · doi:10.1037/0735-7044.102.6.942 · Cited by 125 · see citing works
Cheng, W., Gonzalez, I., Pan, W., Tsang, A. H., Adams, J., Ndoka, E., Gordian, D., Khoury, B., Roelofs, K., Evers, S. S., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2019.12.012 · Cited by 123 · see citing works
Alhadeff, A. L., & Grill, H. J. (2014) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00179.2014 · Cited by 111 · see citing works
Self-citationAlhadeff, A. L., Mergler, B. D., Zimmer, D. J., Turner, C. A., Reiner, D. J., Schmidt, H. D., Grill, H. J., & Hayes, M. R. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.246 · Cited by 102 · see citing works
Self-citationA survey of the mouse hindbrain in the fed and fasted states using single-nucleus RNA sequencing
Dowsett, G. K. C., Lam, B. Y. H., Tadross, J. A., Cimino, I., Rimmington, D., Coll, A. P., Polex-Wolf, J., Knudsen, L. B., Pyke, C., & Yeo, G. S. H. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101240 · Cited by 98 · see citing works
Sex differences in response to short-term high fat diet in mice
Huang, K.-P., Ronveaux, C. C., Knotts, T. A., Rutkowsky, J. M., Ramsey, J. J., & Raybould, H. E. (2020) · Physiology & Behavior · doi:10.1016/j.physbeh.2020.112894 · Cited by 92 · see citing works
Self-citationSequential appetite suppression by oral and visceral feedback to the brainstem
Ly, T., Oh, J. Y., Sivakumar, N., Shehata, S., La Santa Medina, N., Huang, H., Liu, Z., Fang, W., Barnes, C., Dundar, N., et al. (2023) · Nature · doi:10.1038/s41586-023-06758-2 · Cited by 90 · see citing works
Roman, C. W., Sloat, S. R., & Palmiter, R. D. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.06.049 · Cited by 89 · see citing works
Costa, A., Ai, M., Nunn, N., Culotta, I., Hunter, J., Boudjadja, M. B., Valencia-Torres, L., Aviello, G., Hodson, D. J., Snider, B. M., et al. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101407 · Cited by 79 · see citing works
Adriaenssens, A., Broichhagen, J., de Bray, A., Ast, J., Hasib, A., Jones, B., Tomas, A., Burgos, N. F., Woodward, O., Lewis, J., et al. (2023) · JCI Insight · doi:10.1172/jci.insight.164921 · Cited by 77 · see citing works
Self-citationCalcium Sensing Receptor Activators: Calcimimetics
Harrington, P. E., & Fotsch, C. H. (2007) · Current Medicinal Chemistry · doi:10.2174/092986707782794096 · Cited by 75 · see citing works
Competition between stochastic neuropeptide signals calibrates the rate of satiation
Zhang, S. X., Kim, A., Madara, J. C., Zhu, P. K., Christenson, L. F., Lutas, A., Kalugin, P. N., Jin, Y., Pal, A., Tian, L., et al. (2023) · doi:10.1101/2023.07.11.548551 · Cited by 56 · see citing works
Molecular Connectomics Reveals a Glucagon-Like Peptide 1 Sensitive Neural Circuit for Satiety
Webster, A. N., Becker, J. J., Li, C., Schwalbe, D. C., Kerspern, D., Karolczak, E. O., Bundon, C., Onoharigho, R. A., Crook, M., Jalil, M., et al. (2023) · doi:10.1101/2023.10.31.564990 · Cited by 56 · cited 1× · see citing works
“These data emphasize the primacy of NTS signalling in the neural control of food intake and body weight, although it is important to note that our findings do not rule out potential smaller contributions of the hypothalamus or other brain regions to the effects of GLP1-based obesity drugs 10,44,48 .”
Ghidewon, M., Wald, H. S., McKnight, A. D., De Jonghe, B. C., Breen, D. M., Alhadeff, A. L., Borner, T., & Grill, H. J. (2022) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14663 · Cited by 51 · see citing works
Self-citationNausea and Vomiting: a Palliative Care Imperative
Wickham, R. J. (2020) · Current Oncology Reports · doi:10.1007/s11912-020-0871-6 · Cited by 40 · see citing works
Single-Cell Mapping of GLP-1 and GIP Receptor Expression in the Dorsal Vagal Complex
Ludwig, M. Q., Todorov, P. V., Egerod, K. L., Olson, D. P., & Pers, T. H. (2021) · Diabetes · doi:10.2337/dbi21-0003 · Cited by 40 · see citing works
Murphy, S., Glynn, M. C., Dixon, T. N., Grill, H. J., McNally, G. P., & Ong, Z. Y. (2022) · Neuropsychopharmacology · doi:10.1038/s41386-022-01448-5 · Cited by 38 · see citing works
Merchenthaler (1999) · doi:10.1002/(sici)1096-9861(19990111)403:2
Flagged first, then by citations
Cited by
Sorted by citations
Le, R., Nguyen, M. T., Allahwala, M. A., Psaltis, J. P., Marathe, C. S., Marathe, J. A., & Psaltis, P. J. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13164674 · Cited by 66 · see citing works
Weight Reduction with GLP-1 Agonists and Paths for Discontinuation While Maintaining Weight Loss
Reiss, A. B., Gulkarov, S., Lau, R., Klek, S. P., Srivastava, A., Renna, H. A., & De Leon, J. (2025) · Biomolecules · doi:10.3390/biom15030408 · Cited by 58 · see citing works
Brain control of energy homeostasis: implications for anti-obesity pharmacotherapy
Johansen, V. B. I., Petersen, J., Lund, J., Mathiesen, C. V., Fenselau, H., & Clemmensen, C. (2025) · Cell · doi:10.1016/j.cell.2025.06.010 · Cited by 53 · see citing works
GLP-1 and the Neurobiology of Eating Control: Recent Advances
Jones, L. A., & Brierley, D. I. (2025) · Endocrinology · doi:10.1210/endocr/bqae167 · Cited by 43 · see citing works
Incretin receptor agonism rapidly inhibits AgRP neurons to suppress food intake in mice
McMorrow, H. E., Cohen, A. B., Lorch, C. M., Hayes, N. W., Fleps, S. W., Frydman, J. A., Xia, J. L., Samms, R. J., & Beutler, L. R. (2025) · Journal of Clinical Investigation · doi:10.1172/jci186652 · Cited by 12 · see citing works
Liu, X., & Fan, F. (2026) · Frontiers in Toxicology · doi:10.3389/ftox.2026.1731947 · Cited by 4 · see citing works
“…(OPRM1), gut–brain axis regulators (GLP1R, GDF15), and excitability-related channels (CACNA1A), providing mechanistic support for these translational links (Niesler et al., 2008; Joy Lin et al., 2014; Sugino et al., 2014; Borner et al., 2020; Indelicato and Boesch, 2021; Huang et al., 2024).”
- Authors
- Huang, K.-P., Acosta, A. A., Ghidewon, M. Y., McKnight, A. D., Almeida, M. S., Nyema, N. T., Hanchak, N. D., Patel, N., Gbenou, Y. S. K., Adriaenssens, A. E., Bolding, K. A., & Alhadeff, A. L.
- Affiliations
- Monell Chemical Senses Center (US)
- University College London (GB)
- Corresponding author
- Alhadeff, Amber L.
- ORCID
- Venue
- Nature
- Published
- 2024-07-10
- Volume
- 632
- Issue
- 8025
- Pages
- 585-593
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC12519567
- OpenAlex
- W4400491973
- Semantic Scholar
- 8b0bb7a6498911d052f0365c341a0278d2018ac7
- Cited by
- 166
- References
- 79
- Citations by year
- 2026: 62 · 2025: 82 · 2024: 22
- FWCI
- 35.56
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Science Foundation (2236662)
- American Heart Association (898990)
- University of Pennsylvania
- Novo Nordisk Fonden (NNF21SA0072744)
- National Institutes of Health (1s10od030354-01)
- National Institute on Deafness and Other Communication Disorders (R01DC020927)
- National Institute of Diabetes and Digestive and Kidney Diseases (R00DK119574, R01DK131558)
- National Center for Complementary and Integrative Health (DP2AT011965)
- Topics
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Health Sciences › Medicine › Pharmacology › Pharmacology and Obesity Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- GLP-1 receptor, satiety, aversion, nausea and vomiting, obesity drugs, hindbrain, nucleus tractus solitarius, area postrema, two-photon calcium imaging, neural circuits, dietary intake, weight loss
- MeSH terms
- Glucagon-Like Peptide-1 Receptor, Glucagon-Like Peptide-1 Receptor Agonists, Animals, Avoidance Learning, Eating, Female, Food, Male, Mice, Inbred C57BL, Neural Pathways, Neurons, Obesity, Rhombencephalon, Satiety Response, Solitary Nucleus, Anti-Obesity Agents, Area Postrema, Mice, Glucagon-Like Peptide 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-07.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-07.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review